INHIBITION OF MACROAUTOPHAGY AND PROTEOLYSIS IN THE ISOLATED RAT HEPATOCYTE BY A NONTRANSPORTABLE DERIVATIVE OF THE MULTIPLE ANTIGEN PEPTIDE LEU(8)-LYS(4)-LYS(2)-LYS-BETA-ALA
G. Miotto et al., INHIBITION OF MACROAUTOPHAGY AND PROTEOLYSIS IN THE ISOLATED RAT HEPATOCYTE BY A NONTRANSPORTABLE DERIVATIVE OF THE MULTIPLE ANTIGEN PEPTIDE LEU(8)-LYS(4)-LYS(2)-LYS-BETA-ALA, The Journal of biological chemistry, 269(41), 1994, pp. 25348-25353
The multiple antigen peptide derivative, Leu(8)-Lys(4)-Lys(2)-Lys-beta
Ala (Leu(8)-MAP), was synthesized by attaching the carboxyl of leucin
e to the NH2 termini of a branched lysine core, termed MAP, creating a
molecule of about 1900 Da with 8 leucine residues. On a molar basis (
independent pendent of the number of leucine substitutions), Leu(8)-MA
P was as effective as leucine in suppressing macroautophagy and proteo
lysis; moreover, it exhibited the same apparent K-m (about 0.1 mM). Th
e effect was specific for leucine since Ile(8)-MAP was inactive. It is
of interest, though, that Leu(8)-MAP did not elicit the multiphasic r
esponse typical of leucine but instead evoked the single site inhibiti
on normally seen with leucine plus the coregulator alanine. Some free
leucine was produced from Leu(8)-MAP during hepatocyte incubations, bu
t the amounts were insufficient to account for the inhibition. Althoug
h this degradation created species of Leu-MAP that had lost 1-3 residu
es of leucine, their inhibitory effectiveness was not diminished. Beca
use the extracellular/intracellular distribution ratio of [H-3]-Leu(8)
-MAP was 100:1 or greater, the direct transport of Leu(8)-MAP across t
he plasma membrane into the cytosolic compartment can be excluded. Hen
ce, cytosolic concentrations of Leu(8)-MAP will be at least 100-fold s
maller than those of leucine under conditions of comparable proteolyti
c inhibition. For these and related reasons, effects attributable to t
he recognition of Leu(8)-MAP cannot be explained by signals generated
within the cytosol. They could, however, be mediated from site(s) on t
he plasma membrane or within associated vesicles.